Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/19493| Title: | Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use,Breast Neoplasms/*drug therapy/pathology,Carboplatin/administration & dosage,Epirubicin/administration & dosage,Female,Humans,Infusions, Intravenous,Middle Aged,Paclitaxel/administration & dosage,Survival Analysis,Treatment Outcome |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/19493 |
| ISSN: | 0923-7534 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/15367413 http://annonc.oxfordjournals.org/content/15/10/1517.full.pdf |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Fountzilas-2004-Paclitaxel and epiru.pdf | 107.63 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
